Brian Schwartz - 07 Sep 2021 Form 3 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Brian Schwartz
Issuer symbol
N/A
Transactions as of
07 Sep 2021
Net transactions value
$0
Form type
3
Filing time
10 Sep 2021, 12:30:57 UTC
Previous filing
17 Jun 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INFI Stock Option (right to buy) 07 Sep 2021 Common Stock 60,000 $0.9900 Direct F1
holding INFI Stock Option (right to buy) 07 Sep 2021 Common Stock 56,250 $2.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on May 15, 2020. The option agreement provides that the option becomes exercisable in four equal semi-annual installments beginning on October 28, 2020. Pursuant to a resolution approved by the Issuer's Board of Directors on September 1, 2021, all remaining unvested options became exercisable effective as of September 6, 2021.
F2 This option was granted on December 22, 2020. The option agreement provides that the option becomes exercisable in eight equal semi-annual installments beginning on June 22, 2021. Pursuant to a resolution approved by the Issuer's Board of Directors on September 1, 2021, 37,500 unvested options became exercisable effective as of September 6, 2021.